Related Experiment Video
Updated: Sep 30, 2026

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses
Published on: June 13, 2018
[Blood coagulation in domestic deep-seated mycoses]
Maria Ntefidou1, Christine Elsner, Annette Spreer
1St. Vincentius-Kliniken Karlsruhe, Germany.
Abstract:
Activation of blood coagulation to a varying extent affect the course of domestic invasive mycoses. Upon invasion of blood vessels by Candida or aspergilli, occasionally thrombi are formed, which may cause septic embolism. In the course of mucormycosis (syn. zygomycosis) thrombotic occlusion of afflicted blood vessels and subsequent necrosis of dependent tissue regularly occurs. Coagulation during candidosis or aspergillosis may be triggered by secreted aspartic proteinases which are able to activate factor X as has been shown previously [1, 2]. During mucormycosis, severe blood coagulation apparently is due to paracoagulation of fibrinogen which is triggered by low concentrations of extracellular fungal subtilisin-like proteinase (Arp). The enzyme is also able to inactivate the major inhibitor of blood coagulation (antithrombin III). Recent findings on the action of Arp are discussed.
Insights
Invasive fungal infections can activate blood coagulation, leading to thrombi and tissue damage. A fungal enzyme, subtilisin-like proteinase (Arp), triggers severe coagulation in mucormycosis by affecting fibrinogen and antithrombin III.
Area of Science:
- Medical Mycology
- Hematology
- Biochemistry
Context:
- Invasive fungal infections, such as candidosis, aspergillosis, and mucormycosis, can significantly impact blood coagulation.
- Thrombus formation and septic embolism are observed during vascular invasion by Candida and aspergilli.
- Mucormycosis is characterized by regular thrombotic occlusion and tissue necrosis.
Purpose:
- To elucidate the mechanisms by which fungal pathogens activate blood coagulation.
- To investigate the role of fungal proteinases in coagulation disorders during mycoses.
- To discuss recent findings on the action of fungal subtilisin-like proteinase (Arp) in mucormycosis.
Summary:
- Fungal secreted aspartic proteinases can activate factor X in candidosis and aspergillosis.
- In mucormycosis, extracellular fungal subtilisin-like proteinase (Arp) causes severe coagulation via fibrinogen paracoagulation.
- Arp also inactivates antithrombin III, a key inhibitor of blood coagulation.
Impact:
- Understanding these fungal-induced coagulation pathways is crucial for managing invasive mycoses.
- This research highlights potential therapeutic targets for preventing thrombotic complications in fungal infections.
- The findings contribute to the knowledge of host-pathogen interactions in life-threatening fungal diseases.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Fungal Group Zygomycota
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Fungal Phylum Basidiomycota
